CABA vs CALC

Cabaletta Bio, Inc. vs CalciMedica, Inc. — Valuation Comparison 2026

CABA

Biotechnology
Cabaletta Bio, Inc.
Quality
4.4
out of 10
Value Trap
24
SAFE
Price
$3.77
Last close
Models
7/13
Active
VS

CALC

Biotechnology
CalciMedica, Inc.
Quality
4.4
out of 10
Value Trap
18
SAFE
Price
$0.87
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType CABA Fair ValueCABA Upside CALC Fair ValueCALC Upside
Bayesian DCF Intrinsic $1.10 -70.8% $0.52 -40.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.45 -61.4% $2.58 +196.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CABA vs CALC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CABA vs CALC — Which Stock Is More Undervalued?

CABA scores higher with a 4.4/10 quality rating vs CALC's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cabaletta Bio, Inc. (CABA) and CalciMedica, Inc. (CALC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CABA currently trades at $3.77 with a QOC of 4.4/10, while CALC trades at $0.87 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).